| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 5 | +1.59 M | 99.3% | $27.20 | +$43.3 M |
| Sells | 1 | -11 K | 0.7% | $41.79 | -$460 K |
| Net | +4 | +1.58 M | 98.6% | +$42.9 M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| John W. Childs | Director | $229 M | +$22.9 M | +11.1% | May 30, 2024 |
| Vlad Coric | Chief Executive Officer, Director | $129 M | +$15 M | +13.2% | Apr 22, 2024 |
| Gregory Bailey | Director | $55.2 M | +$3.91 M | +7.63% | May 13, 2024 |
| Matthew Buten | Chief Financial Officer | $4.17 M | +$500 K | +13.6% | Jan 2, 2024 |
| Bruce Car | Chief Scientific Officer | $1.09 M | +$1.01 M | +1259% | Jun 17, 2024 |
| Irina Antonijevic | Director | $106 K | -$460 K | -81.3% | Apr 30, 2024 |
| Kishan Mehta | Director | Apr 30, 2024 | |||
| George Clark | VP, Chief Accounting Officer | Jan 2, 2024 | |||
| Robert J. Hugin | Director | Apr 30, 2024 | |||
| Michael Thomas Heffernan | Director | Apr 30, 2024 | |||
| Biohaven Pharmaceutical Holding Co Ltd. | 10%+ Owner | Oct 3, 2022 | |||
| Julia P. Gregory | Director | Apr 30, 2024 | |||
| Kimberly Gentile | SVP, Clinical Operations | Jan 2, 2024 |
| Insider | Class | Transaction | % | Value $ | Price $ | Shares | Shares Owned | Date | Ownership |
|---|